Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study of the Oral γ-Secretase Inhibitor BMS-708163 (Avagacestat): Tolerability Profile, Pharmacokinetic Parameters, and Pharmacodynamic Markers

Autor: Tong, Gary 1, ⁎, Wang, Jun-Sheng 1, Sverdlov, Oleksandr 2, Huang, Shu-Pang 2, Slemmon, Randy 1, Croop, Robert 2, Castaneda, Lorna 1, Gu, Huidong 2, Wong, Oi 2, Li, Hewei 2, Berman, Robert M. 3, Smith, Christina 2, Albright, Charles F. 3, Dockens, Randy C. 1
Zdroj: In Clinical Therapeutics March 2012 34(3):654-667
Databáze: ScienceDirect